Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Dalbavancin HCL (CDM PH018737) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 2, 2026 , from http://ppman.hank.ai/transparency/procedure/PH018737/by-state?code_type=CDM
“Dalbavancin HCL (CDM PH018737) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/PH018737/by-state?code_type=CDM. Accessed
July 2, 2026 .
“Dalbavancin HCL (CDM PH018737) by State,” HANK Price Transparency ,
accessed July 2, 2026 ,
http://ppman.hank.ai/transparency/procedure/PH018737/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
PH018737 — Dalbavancin Hcl
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$7,387
National median
$6,405 – $8,412
IQR (p25 – p75)
1
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$8,540
vs. negotiated
+15.6%
Hospitals reporting
3
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for PH018737 (CDM), with interquartile range
State Median p25 p75
TX $7,387 $6,405 $8,412